Predictive value of intra‐tumoural TCRβ rearrangements in precisely selecting adjuvant therapy for EGFR‐mutant non‐small‐cell lung cancer

Predictive value of intra‐tumoural TCRβ rearrangements in precisely selecting adjuvant therapy for EGFR‐mutant non‐small‐cell lung cancer

Abstract In this commentary, we discussed the important role of intratumoural specific T‐cell receptor (TCR) β chain rearrangements on tumour‐infiltrating lymphocytes in predicting clinical outcomes of adjuvant tyrosine kinase inhibitor therapy or chemotherapy in patients with non‐small‐cell lung ca...

Full description

Bibliographic Details
Main Authors: Cunte Chen #, Si‐Yang Maggie Liu #, Yi‐Long Wu, Si‐Yang Liu, Yangqiu Li
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Clinical and Translational Discovery
Subjects:
adjuvant TKI
EGFR mutation
non‐small‐cell lung cancer
prognosis
TCR rearrangement
Online Access:https://doi.org/10.1002/ctd2.46

Internet

https://doi.org/10.1002/ctd2.46

Similar Items